Theoretic background of therapy with monoamine oxidase inhibitors in cardiology
- 1 December 1960
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 6 (6) , 1121-1124
- https://doi.org/10.1016/0002-9149(60)90374-x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- SIGNIFICANCE OF MONOAMINE OXIDASE INHIBITION FOR THE PHARMACOLOGICAL AND CLINICAL EFFECTS OF HYDRAZINE DERIVATIVESAnnals of the New York Academy of Sciences, 2006
- PHARMACOLOGY OF JB‐516 (PIH)Annals of the New York Academy of Sciences, 1959
- IPRONIAZID IN CARDIOVASCULAR THERAPY, WITH SPECIAL REFERENCE TO ITS ACTION IN ANGINA PECTORIS AND BLOOD PRESSUREAnnals of the New York Academy of Sciences, 1959
- Abschwächung der Noradrenalin-Wirkung auf die isolierte Aorta bei Hemmung der MonoaminoxydaseCellular and Molecular Life Sciences, 1959
- Ganglionic Block and Monoamine Oxidase InhibitorsNature, 1959
- Iproniazid (Marsilid) in angina pectorisAmerican Heart Journal, 1958
- Histochemische Untersuchungen über den Einfluss von Iproniazid (Marsilid) auf die durch Reserpin erzeugte Freisetzung von Adrenalin und Noradrenalin aus dem NebennierenmarkCellular and Molecular Life Sciences, 1958
- Increase of 5-Hydroxytryptamine in Blood Platelets by Isopropyl-isonicotinic Acid HydrazideNature, 1958
- The output of sympathetic transmitter from the spleen of the catThe Journal of Physiology, 1957
- Adrenergic blockade by iproniazidCellular and Molecular Life Sciences, 1955